26Feb 2018
BACTERIOLOGICAL STUDY OF VENTILATOR-ASSOCIATED PNEUMONIA IN A TERTIARY CARE HOSPITAL.
- Assistant Professor, Department of Microbiology, Government Medical College, Nagpur.
- Professor & Head, Department of Microbiology, Government Medical College, Nagpur.
- Abstract
- Keywords
- References
- Cite This Article as
- Corresponding Author
Ventilator-associated pneumonia (VAP) is the most common nosocomial infection diagnosed in the intensive care units (ICUs). Microorganisms responsible for ventilator associated pneumonia vary from place to place. VAP requires a rapid diagnosis and initiation of the antibiotic treatment.The present study was carried out to detect bacteria commonly associated with VAP and determine their susceptibility patterns including beta-lactamases production. Out of a total 1438 patients intubated for more than 48 hours, 302 patients (21.0%) were clinically diagnosed as VAP cases. The VAP rate was found to be 2.06 cases per 1000 ventilator days. A. baumannii (38.11%), P. aeruginosa (26.74%), K. pneumoniae (14.85%), S.aureus (11.38%), E. coli (3.96%), C. freundii (1.98%), A. lwoffi (1.98%) and P. mirabilis (0.99%) were isolated. Amongst the gram negative isolates, 15.64% were ESBL, 11.73% were AmpC and 13.96% were MBL producers. Early diagnosis of VAP along with their sensitivity pattern will help as an epidemiological marker for initial prophylaxis and treatment planning for mechanically ventilated patients.
1. Ranjan N, Chaudhary U, Chaudhry D, Ranjan KP. Ventilator-associated pneumonia in a tertiary care intensive care unit: Analysis of incidence, risk factors and mortality. Indian Journal of Critical Care Medicine. 2014; 18(4): 200-4.
2. Chastre J and Fagon JY. Ventilator-associated pneumonia. Am J RespirCrit Care Med. 2002; 165: 867-903.
3. Morehead RS and Pinto SJ Ventilator-associated pneumonia. Arch Intern Med. 2000; 160: 1926-36.
4. Joseph NM, Sistla S, Dutta TK, Badhe AS, Parija SC. Ventilator-associated pneumonia in a tertiary care hospital in India: incidence and risk factors. J Infect Dev Ctries. 2009; 3: 771-77.
5. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in vSentilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med.1993; 94: 281-88.
6. Crouch Brewer S, Wunderink RG, Jones CB, Leeper KV. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest.1996; 109: 1019-29.
7. Rello J, Quintana E, Ausina V, Castella J, Luquin M, Net A, and Prats G. Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest.1991; 100: 439-44.
8. Fagon JY, Chastre J, Vuagnat A, Trouillet JL, Novara A and Gibert C. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA.1996; 275: 866-69.
9. Dey A and Bairy I. Incidence of multidrug-resistant organisms causing ventilator-associated pneumonia in a tertiary care hospital: A nine months' prospective study. Ann Thorac Med. 2007; 2(2): 52-7.
10. Collee JG, Duguid JP, Fraser AG, Marmion BP, Simmons A. Laboratory strategy in the diagnosis of infective syndromes. In Collee JG, Fraser AG, Marmion BP, Simmons A (eds.). Mackie and McCartney Practical Medical Microbiology, 14th Ed, Churchill Livingstone, Delhi, 2007; p 53 -94.
11. Apostolopoulou E, Bakakos P, Katostaras T, Gregorakos L. Incidence and risk factors for ventilator-associated pneumonia in 4 multidisciplinary intensive care units in Athens, Greece. Respir Care. 2003; 48(7): 681-8.
12. CLSI 2013: Performance standard for Antimicrobial Susceptibility Testing; Twenty-third informational supplement; M100-S23. Vol.33 No.1 Clinical and laboratory standard institute, Wayne, Pa, USA.
13. Miles RS, Amyes SGB. Laboratory control of antimicrobial therapy. In Colle JG, Fraser AG, Marmion BP, Simmons A, eds. Mackie and McCartney. Practical Medical Microbiology. 14th ed; New York: Churchill Livingstone.1996; 151-78.
14. Singhal S, Mathur T, Khan S, Upadhyay DJ, Chugh S, Gaind R, Rattan A. Evaluation of methods for AmpC beta-lactamase in Gram negative clinical isolates from tertiary care hospitals. Ind J Med Microbiol. 2005; 23(2): 120-4.
15. Joseph NM, Menezes GA, Harish BN, Sujatha S, Parija SC. Simple screening tests for detection of carbapenemases in clinical isolates of non-fermentative Gram-negative bacteria. Indian J Med Res 2009; 129: 707-12.
16. Forbes BA, Sahm DF, Weissfeld AS. Laboratory methods and strategies for antimicrobial susceptibility testing. In Bailey and Scott?s Diagnostic Microbiology, 12th Ed, Mosby, Missouri, 2007, p 187-214.
17. Hemalatha V, Sekar U, Kamat V. Detection of metallo-betalactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J Med Res. 2005; 122(2): 148-52.
18. Picao RC, Andrade SS, Nicoletti AG, Campana EH, Moraes GC, Mendes RE et al. Metallo-β-Lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates. J Clin Microbiol. 2008; 46(6): 2028-37.
19. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallo-β-lactamase producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J ClinMicrobiol. 2002; 40(10): 3798-3801.
20. Skov R, Smyth R, Larsen AR, Bolmstrτm A, Karlsson A, Mills K, Frimodt-moller N, Kahlmeter G. Phenotypic detection of methicillin resistance in Staphylococcus aureus by disk diffusion testing and Etest on Mueller-Hinton agar. J Clin Microbiol. 2006; 44: 4395-9.
21. Mathews A, Thomas M, Appalaraju B, Jayalakshmi J. Evaluation and comparison of tests to detect methicillin resistant S. aureus. Indian J Pathol Microbiol. 2010; 53: 79-82.
22. Mohansoundaram KM, Lalitha MK. Comparison of phenotypic versus genotypic methods in the detection of Methicillin resistance in Staphylococcus aureus. Indian J Med Res. 2008; 127: 78.
23. Bowton DL, Hite RD, Martin RS, Sheretz R. The impact of hospitalwide use of a tapered cuff endotracheal tube on the incidence of ventilator-associated pneumonia. Respir Care. 2013; 58(10): 1582?87.
24. Panwar R, Nagar VS, Deshpande AK. Incidence, clinical outcome, and risk stratification of ventilator-associated pneumonia-a prospective cohort study. Indian J Crit Care Med. 2005; 9(4): 211-16.
25. Joseph N, Sistla S, Dutta T, Badhe A, Rasitha D, Parija S. Ventilator-associated pneumonia in a tertiary care hospital in India: role of multi-drug resistant pathogens. The Journal Of Infection In Developing Countries. 2010; 4 (04): 218-25.
26. Alqurashi AM. Antibiotic susceptibility patterns of different bacteria isolated from patients with ventilator associated pneumonia (VAP). Journal of Family and Community Med. 2005; 12(3): 139-44.
27. Ali Abdel Rahim KA and Ali Mohamed AM. Prevalence of extended spectrum β-lactamase producing Klebsiella pneumoniae in Clinical Isolates. Jundishapur J Microbiol. 2014; 7(11): 1-5.
28. Duran N, Ozer B, Duran G, Onlen Y, Demir C. Antibiotic resistance genes & susceptibility patterns in staphylococci. Indian J Med Res. 2012; 389-96.
29. Gopalkrishnan R, Dorairajan S. Changing trends in antimicrobial susceptibility and hospital acquired infections over an 8 year period in a tertiary care hospital in relation to introduction of an infection control programme. J Assoc Physician India, 2010; 58: 25-31.
30. Galani I, Rekatsina PD, Hatzaki D et al. Evaluation of different laboratory tests for detection of metallo-β lactamase production in Enterobacteriaceae. J Antimicrob Chemotherapy 2008; 25: 1-6.
31. Arora S, Devi P, Arora U, Devi B. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in a tertiary care hospital in Northern India. J Lab Physicians. 2010; 2: 78-81.
[Trupti D. Satpute and Sunanda N. Shrikhande. (2018); BACTERIOLOGICAL STUDY OF VENTILATOR-ASSOCIATED PNEUMONIA IN A TERTIARY CARE HOSPITAL. Int. J. of Adv. Res. 6 (Feb). 1770-1774] (ISSN 2320-5407). www.journalijar.com
Dr. Trupti D. Satpute
Assistant Professor, Department of Microbiology, Government Medical College, Nagpur.
Assistant Professor, Department of Microbiology, Government Medical College, Nagpur.
